Impact of statins as immune-modulatory agents on inflammatory markers in adults with chronic diseases: A systematic review and meta-analysis
PLOS One · 29.05.2025 · 20 (5) · e0323749
DOI: 10.1371/journal.pone.0323749 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift PLOS One, online erschienen am 29.05.2025. Verfasst von Solima Sabeel und 14 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Infectious Diseases and Molecular Medicine (IDM), Department of Pathology, Division of Immunology, Faculty of Health Sciences, Universit…. Hauptthemen laut MEDLINE: Hydroxymethylglutaryl-CoA Reductase Inhibitors, Inflammation, Immunomodulating Agents. Die Arbeit wurde bisher 37-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: EDCTP2, Wellcome Centre for Infectious Diseases Research in Africa.
Abstract (Originalsprache)
While numerous studies have extensively documented the pleiotropic effects of statins, including their capacity to reduce inflammation, there is a lack of research estimating the anti-inflammatory effectiveness of statins among individuals with chronic diseases. This meta-analysis evaluates the effect of statin therapy on inflammatory markers and the lipid profile in patients with chronic diseases by analysing evidence from randomized controlled trials (RCTs). We conducted a systematic review and searched articles published between 1 st January 1999 and 31 st December 2023 in databases including PubMed, Web of Science, Scopus, and Cochrane. The meta-analysis was performed using random effects models and inverse variance. Effect measures were mean differences (MD) and 95% confidence intervals (CI). Collectively, statins significantly reduced IL-6 ( MD = -0.24 ng/dL [95% CI, -0.36 to -0.13], I 2 = 98.3%, p < 0.001 ), TNF-α ( MD = -0.74 ng/dL [95% CI, -1.08 to -0.40], I 2 = 98.8%, p < 0.001 ); and CRP ( MD = -1.58 mg/L [95% CI, -2.22 to -0.94], I 2 = 86.5%, p < 0.001 ). Notably, atorvastatin demonstrated the most significant reduction in IL-6 and TNF-α levels, while fluvastatin and rosuvastatin displayed the greatest impact on decreasing CRP and LDL-C levels, respectively. Stratification by a longer treatment duration of more than four months revealed that atorvastatin achieved the most significant reduction in IL-6 and TNF-α. In conclusion, statin therapy not only regulates the lipid profile but also reduces systemic inflammatory biomarkers. Prolonged administration of statins led to a more substantial reduction in IL-6 and TNF-α, with atorvastatin exhibiting the greatest effect in our analysis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Institute of Infectious Diseases and Molecular Medicine (IDM), Department of Pathology, Division of Immunology, Faculty of Health Sciences, University of Cape Town, South Africa.
- International Centre for Genetic Engineering and Biotechnology (ICGEB), Cape Town Component, Cape Town, South Africa.
- Non-Communicable Diseases Research Unit, South African Medical Research Council, Cape Town, South Africa.
- General Medicine & Global Health (GMGH), Department of Medicine and Cape Heart Institute, Faculty of Health Science, University of Cape Town, South Africa.
- Division of Lipidology, Department of Medicine and Cape Heart Institute, University of Cape Town, South Africa.
- Cape Heart Institute and Division of Cardiology, Department of Medicine, Faculty of Health Sciences, University of Cape Town, South Africa.
ORCID-Profile: Solima Sabeel, Bongani Motaung, Kim A Nguyen, Mumin Ozturk, Robert J Wilkinson, Friedrich Thienemann
Förderung
- EDCTP2
- Wellcome Centre for Infectious Diseases Research in Africa
Zitieren
APA
Sabeel, S., Motaung, B., Nguyen, K. A., Ozturk, M., Mukasa, S. L., Wolmarans, K., Blom, D. J., Sliwa, K., Nepolo, E., Günther, G., Wilkinson, R. J., Schacht, C., Kengne, A. P., Thienemann, F., & Guler, R. (2025). Impact of statins as immune-modulatory agents on inflammatory markers in adults with chronic diseases: A systematic review and meta-analysis. PLOS One, 20(5), e0323749. https://doi.org/10.1371/journal.pone.0323749
Vancouver
Sabeel S, Motaung B, Nguyen KA, Ozturk M, Mukasa SL, Wolmarans K, et al. Impact of statins as immune-modulatory agents on inflammatory markers in adults with chronic diseases: A systematic review and meta-analysis. PLOS One. 2025;20(5):e0323749. doi:10.1371/journal.pone.0323749
BibTeX
@article{Sabeel2025,
author = {Sabeel, Solima and Motaung, Bongani and Nguyen, Kim A and Ozturk, Mumin and Mukasa, Sandra L and Wolmarans, Karen and Blom, Dirk J and Sliwa, Karen and Nepolo, Emmanuel and Günther, Gunar and Wilkinson, Robert J and Schacht, Claudia and Kengne, Andre Pascal and Thienemann, Friedrich and Guler, Reto},
title = {Impact of statins as immune-modulatory agents on inflammatory markers in adults with chronic diseases: A systematic review and meta-analysis},
journal = {PLOS One},
year = {2025},
volume = {20},
number = {5},
pages = {e0323749},
doi = {10.1371/journal.pone.0323749}
}
EUVIMED